戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 his may provide new treatment modalities for Acanthamoeba keratitis.
2 reen new anti-infectives in the treatment of Acanthamoeba keratitis.
3 ould test the validity of this treatment for Acanthamoeba keratitis.
4  corneal scrapings from bacterial, viral, or Acanthamoeba keratitis.
5 a) inhibitors may be a therapeutic target in Acanthamoeba keratitis.
6 al-time PCR assays could be used to diagnose Acanthamoeba keratitis.
7 P-133 produce an additive protection against Acanthamoeba keratitis.
8 ubsequent steps of the pathogenic cascade of Acanthamoeba keratitis.
9 hat mediate latex bead-induced resistance to Acanthamoeba keratitis.
10 astellanii antigens fails to protect against Acanthamoeba keratitis.
11 innate immune apparatus in the resistance to Acanthamoeba keratitis.
12 ils in latex-bead-induced protection against Acanthamoeba keratitis.
13 ge amounts of mannose and is associated with Acanthamoeba keratitis.
14  4 patients underwent diagnostic testing for Acanthamoeba keratitis.
15 o chlorhexidine, a drug widely used to treat Acanthamoeba keratitis.
16 ubsequent steps of the pathogenic cascade of Acanthamoeba keratitis.
17 nt an important immunotherapeutic target for Acanthamoeba keratitis.
18 high numbers in the corneas of patients with Acanthamoeba keratitis.
19 topical steroid is used in the management of Acanthamoeba keratitis.
20 a, such as herpes simplex virus keratitis or Acanthamoeba keratitis.
21 e and A. griffini is reported from a case of Acanthamoeba keratitis.
22 tic potential, particularly for herpetic and Acanthamoeba keratitis.
23 08.9 +/- 812.5 cells/mm(2); P < 0.0001), and Acanthamoeba keratitis (1000.2 +/- 1090.3 cells/mm(2); P
24                                              Acanthamoeba keratitis, a rare eye disease primarily aff
25         The soil amoebae Acanthamoeba causes Acanthamoeba keratitis, a severe sight-threatening infec
26 g these disorders, fungal keratitis (FK) and acanthamoeba keratitis (AK) are particularly severe and
27  a non-invasive, rapid method for diagnosing Acanthamoeba keratitis (AK) by detecting cysts or tropho
28                        Quantify and describe Acanthamoeba keratitis (AK) cases in British Columbia (B
29 stablish risk factors for the development of Acanthamoeba keratitis (AK) for daily disposable (DD) co
30                             The incidence of acanthamoeba keratitis (AK) in the UK is some 15 times t
31                                              Acanthamoeba keratitis (AK) is a rare but sight-threaten
32                                              Acanthamoeba keratitis (AK) is a very painful and vision
33                                   Nearly all Acanthamoeba keratitis (AK) isolates are genotype RnsT4.
34  eight distinct clades, with seven including Acanthamoeba keratitis (AK) isolates.
35 l microscopy diagnostic criteria to diagnose Acanthamoeba keratitis (AK) using polymerase chain react
36 lls, a key first step in the pathogenesis of Acanthamoeba keratitis (AK), a devastating corneal infec
37 as the causative agent of sight- threatening Acanthamoeba keratitis (AK), serious infections of other
38 ve agent for the sight threatening infection Acanthamoeba keratitis (AK).
39 tchetti are frequently identified as causing Acanthamoeba keratitis (AK).
40 ision-threatening corneal infection known as Acanthamoeba keratitis (AK).
41 crapings of Scottish patients with suspected Acanthamoeba keratitis (AK).
42  subgenus group associated most closely with Acanthamoeba keratitis (AK).
43   To provide an overview on the incidence of Acanthamoeba keratitis (AK).
44      Oral immunization with MIP133 mitigates Acanthamoeba keratitis and demonstrates the feasibility
45 pecifically, there has been an insurgence of Acanthamoeba keratitis and Fusarium keratitis.
46 stromal edema are frequently associated with Acanthamoeba keratitis, as well as in Acanthamoeba coinf
47 entially with herpes simplex keratitis, then Acanthamoeba keratitis before referral.
48                          The pathogenesis of Acanthamoeba keratitis begins when Acanthamoeba trophozo
49  (aPA) play key roles in the pathogenesis of Acanthamoeba keratitis by inducing a cytopathic effect o
50                              Confirmation of Acanthamoeba keratitis by laboratory diagnosis is the fi
51                                              Acanthamoeba keratitis emerged as a relatively low-incid
52 n findings can be useful for differentiating acanthamoeba keratitis from bacterial and fungal keratit
53 immune apparatus are important in preventing Acanthamoeba keratitis from progressing to become an int
54 e predominance of Rns genotype T4 strains in Acanthamoeba keratitis infections.
55 at the initial phases in the pathogenesis of Acanthamoeba keratitis involve parasite binding and lysi
56                                              Acanthamoeba keratitis is a chronic inflammatory disease
57                          The pathogenesis of Acanthamoeba keratitis is a complex, sequential process.
58                                              Acanthamoeba keratitis is a debilitating eye disease tha
59                                              Acanthamoeba keratitis is a serious vision-threatening d
60                                              Acanthamoeba keratitis is a sight-threatening corneal in
61                                              Acanthamoeba keratitis is a sight-threatening infection
62                                              Acanthamoeba keratitis is a vision-threatening corneal i
63                            Here we show that Acanthamoeba keratitis is profoundly affected by mannosy
64 s are among the most ubiquitous amoebae, yet Acanthamoeba keratitis is remarkably rare.
65 ial keratitis, epithelial regeneration line, Acanthamoeba keratitis, mucus plaque keratopathy, medica
66           The unexplained persistence of the Acanthamoeba keratitis outbreak in the United States, cl
67 , specimens isolated from the faucets at two Acanthamoeba keratitis patients' homes differed from the
68 or for case contamination among Fusarium and Acanthamoeba keratitis patients.
69                                              Acanthamoeba keratitis risks are increased > threefold i
70                                              Acanthamoeba keratitis risks for DD lens users can be mi
71 tis, and 115 patients with laboratory-proven acanthamoeba keratitis seen at Aravind Eye Hospital, Mad
72                 The profound exacerbation of Acanthamoeba keratitis seen when neutrophil migration wa
73 he potential of this Rns region for tracking Acanthamoeba keratitis strains in infections and for dis
74 ifferentiating features were more common for acanthamoeba keratitis than for bacterial or fungal kera
75 tex beads induces a remarkable resistance to Acanthamoeba keratitis that is largely, if not entirely,
76 mined the use of adjuvant AMT in herpetic or Acanthamoeba keratitis, though the benefit was supported
77 oscopy could be useful in cases of fungal or acanthamoeba keratitis to determine the depth of infecti
78                                              Acanthamoeba keratitis was defined as the presence of AK
79                                              Acanthamoeba keratitis was diagnosed on microbiological
80 neal infection in a Chinese hamster model of Acanthamoeba keratitis was examined in vivo.
81 bacterial or fungal keratitis, patients with acanthamoeba keratitis were more likely to be younger an
82 ral immunization with Ac-CT protects against Acanthamoeba keratitis when administered before corneal
83 s adverse events, particularly bacterial and Acanthamoeba keratitis while using these lenses, althoug
84  with fungal keratitis, and 93 patients with acanthamoeba keratitis who had medical records available
85 dies reporting resolution or modification of Acanthamoeba keratitis without specific antiacanthamoeba